Clinical Trials

Posters and Publications

		Articles
		2009
		2008
		2007
		2006
		2005
		2004
		2003
		2002
		2001
		2000

Note: Not all studies are available based on copyrights of the original documents. Please note the PARI Pharma copyright studies are owned by PARI Pharma. Data may not be referenced in any way including print and electronic formats without the prior written consent of PARI Pharma.

[DDL 12-05 018] R. Stangl: Development of a Nebulizer Product Platform Drug Delivery to the Lungs XVI, Edinburgh, United Kingdom, December 7 – 9, 2005 (poster). Proceedings pp. 242-245 (extended abstract)
[DDL 12-05 017] M. Tservistas, K. Reul, A. Luithlen, I. Friedrich, A. Bucholski, M. Keller: Correlation of data from Andersen and Next Generation Impactor compared to Laser Diffractometry. Drug Delivery to the Lungs XVI, Edinburgh, United Kingdom, December 7-9, 2005 (poster). Proceedings pp. 257-260 (extended abstract).
[DDL 12-05 016] I. Friedrich, S. von Opolski, A. Braun, M. Tservistas, M. Keller: Colloidal formulations to improve drug delivery by eFlow®, a new electronic nebuliser. Drug Delivery to the Lungs XVI, Edinburgh, United Kingdom, December 7 – 9, 2005 (poster). Proceedings pp.125-128 (extended abstract).
[DDL 12-05 015] M. Keller, A. Akkar, A.Krüner, R. Mehrwald, E. Haltner: Assessment of Applicability and Tolerability of Drugs and Excipients on Calu-3 Cells, a Bronchial Epithelial Cell Model. Drug Delivery to the Lungs XVI, Edinburgh, United Kingdom, December 7 – 9, 2005 (poster). Proceedings pp. 161-164 (extended abstract).
R. Evans, M. E. Bogden, M. Tservistas, A. Braun, S. Seemann, M. Keller: Comparison of the Rates of Drug Delivery and the Relative Efficiencies of Emitted and Respirable Dose for Two Different Nebulizers Yielding Qualitatively Similar Aerosols. Drug Delivery to the Lungs XVI, Edinburgh, United Kingdom, December 7 – 9, 2005 (poster). Proceedings pp. 121-124 (extended abstract).
[AAPS 11-05 014] A. Raposo, A. Akkar, E. Haltner, M. Keller: Cyclodextrin Nanoparticles Loaded with Cyclosporin A for Inhalation. AAPS Annual Meeting, Nashville, TN, USA,November 6 – 10, 2005 (poster).
[NACF 10-05 013] U. Schuschnig, M. Keller, M. Surber, K. Bostian: In-Vitro Nebulization Assessment of the Efflux Pump Inhibitor MP-601,205 Delivered by the eFlow® Electronic Inhaler. North American Cystic Fibrosis Conference (NACF), Baltimore, USA, October 20 – 23, 2005 (poster).
[NACF 10-05 012] A. Akkar, A. Raposo, R. Mehrwald, M. Bultmann, M. Knoch, M. Keller: Assessment of the Nebulization Efficiency of a Novel Aqueous Cyclosporin Formulation by eFlow®. North American Cystic Fibrosis Conference (NACF), Baltimore, USA,October 20 – 23, 2005 (poster).
[NACF 10-05 011] U. Schuschnig, M. Luber, Y. Waehner, G. Hunziker, H. Mentzel, A. Raposo, M. Keller In-Vitro Deposition Study of a Novel Antibiotic Solution into Nasal Cast Cavities be the PARI SINUS™ Aerosol Delivery System. North American CysticFibrosis Conference (NACF), Baltimore, USA, October 20 – 23, 2005 (poster).
[NACF 10-05 010] R. Evans, M. Ellis Bogden, M. Tservistas, S. Seemann, M. Keller: Optimization of Aerosol Characteristics of the eFlow® Electronic Nebulizer for Pulmonary Delivery of a P2Y2 Agonist. North American Cystic Fibrosis Conference (NACF),Baltimore, USA, October 20 – 23, 2005 (poster).
[ERS 09-05 009] M. Keller, A. Bucholski, S. Seemann, M. Hug, A. Schmitt, M. Knoch: Reduction in nebulisation time of aqueous drug solutions by the eFlow® rapid in comparison to a jet nebuliser to improve patient convenience and compliance. European Respiratory Society, annual congress 2005, Copenhagen, Denmark, September 17 – 21, 2005 (poster). European Respiratory Journal, vol. 26, suppl. 49, 2005, p. s338.
[ECFC 06-05 008] M. Keller, A. Bucholski, A. Balcke, K. Reul, M. Knoch: Assessment of nebulisation efficiency of a reduced Glutathion-Sodium solution (GSH) by a PARI LC STAR® and the eFlow® electronic nebuliser. European Cystic Fibrosis Society, 28th European Cystic Fibrosis Conference, Crete, Greece, June 22-25, 2005 (poster).
[ECFC 06-05 007] U. Schuschnig, M. Luber, Y. Waehner, G. Hunziker, H. Mentzel, A. Raposo, M. Keller In-vitro deposition study of a novel antibiotic solution into nasal cast cavities by the PARI SINUS™ aerosol delivery system. European Cystic Fibrosis Society, 28th European Cystic Fibrosis Conference, Crete, Greece, June 22-25, 2005 (poster).
[ECFC 06-05 006] M. Keller, A. Bucholski, M. Hug, H. Meyer, M. Knoch: Shorter nebulisation time and droplet design for drug targeting of a novel tobramycin formulation (100 mg/ml) achieved by the eFlow® electronic nebuliser compared to TOBI® nebulised by the PARI LC PLUS®. European Cystic Fibrosis Society, 28th European Cystic Fibrosis Conference, Crete, Greece, June 22-25, 2005 (poster).
[ECFC 06-05 005] S. Seemann, M. Hug, R. Lichtinghagen, A. Schmitt, M. Tservistas, R. Waldner, M.Knoch: Improving aerosol drug delivery in CF therapy. European Cystic Fibrosis Society, 28th European Cystic Fibrosis Conference, Crete, Greece, June 22-25, 2005 (poster).
[ATS 05-05 004-01] M. Keller, A. Bucholski, M. Hug: Effect of Nebulizer Type on the Delivery Efficiency of Pulmicort® Suspension Respules Compared to Novel Aqueous Budesonide Solutions. International Conference of the American Thoracic Society (ATS), May 20 – 25, 2005, San Diego, USA (poster).
[ATS 05-05 003-01] M. Keller, A. Bucholski, G. Lang, H. Meyer: In-Vitro Equivalence and Shorter Nebulization Time Using a Novel Tobramycin (100 mg/ml) Solution and eFlow® Compared to TOBI® (300 mg/5 ml) Nebulized by the PARI LC PLUS®. International Conference of the American Thoracic Society (ATS), May 20 – 25, 2005, San Diego, USA (poster). M. Knoch, M. Keller: The customised electronic nebuliser: a new category of liquid aerosol drug delivery system. Expert Opin. Drug Deliv. 2005, 2(2), pp. 377-390.
[ISAM 03-05 002] M. Tservistas, F.-C. Lintz, S. von Opolski, M. Hug, M. Keller, M. Knoch: Improving drug delivery performance by customization of formulation and nebulizer. International Society of Aerosols in Medicine (ISAM), 15th International Congress, Perth, Australia, March 14-18, 2005 (poster).
[ISAM 03-05 001] R. Stangl, S. Seemann, M. Knoch: Customizing an Electronic Nebulizer. International Society of Aerosols in Medicine (ISAM), 15th International Congress, Perth, Australia, March 14-18, 2005 (poster)